<DOC>
	<DOCNO>NCT01119287</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Maxidex Patanol compare placebo patient allergic conjunctivitis expose control allergen level Environmental Exposure Chamber ( EEC ) .</brief_summary>
	<brief_title>Assessing Efficacy Maxidex® Patanol® Treatment Allergic Conjunctivitis</brief_title>
	<detailed_description>This study consist 6 visit . Visit 1 Medical Screening Visit ( skin prick test ) . Visit 2 Visit 3 consist 2 consecutive EEC Visits ( 3 hour EEC follow 7 hour Clinic , 10 hour total , visit ) follow 7 day wash-out . Visit 2 Visit 3 occur prior dispense measure obtain visit use baseline . At Visit 4 patient randomize dispensed assign study medication 7 day at-home dosing . Visit 5 ( Day 8 treatment ) Visit 6 ( Day 9 treatment ) consist 2 additional consecutive EEC Visits ( 3 hour EEC follow 7 hour clinic , 10 hour total , visit ) . During EEC visit , patient expose either ragweed cat allergen , depend skin prick test result . Of 180 participant enrol , 170 receive least one dose study treatment randomize one three study treatment .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>At least 1 year history allergic conjunctivitis . Ability self administer ophthalmic drop . Ability avoid use disallowed medication entire study period specify period prior visit 1 . Other protocolspecified inclusion criterion may apply . Presence ocular infection . Confirmed diagnosis dry eye . Presence glaucoma ocular hypertension . Moderate severe asthma . Any severe , unstable , uncontrolled systemic disease . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Conjunctivitis</keyword>
	<keyword>ocular allergy</keyword>
</DOC>